Amyloid burden and neural function in people at risk for Alzheimer's Disease. - sprookjes - yvandenbroek - TriplyDB

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

http://www.wikidata.org/entity/Q33599047

about

Three Large-Scale Functional Brain Networks from Resting-State Functional MRI in Subjects with Different Levels of Cognitive Impairment Cognitive reserve and lifestyle: moving towards preclinical Alzheimer's disease The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.Insulin resistance predicts brain amyloid deposition in late middle-aged adults.Early detection of Alzheimer's disease using PiB and FDG PET Physical activity attenuates age-related biomarker alterations in preclinical AD Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults.APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition.β-Amyloid Deposition Is Associated with Decreased Right Prefrontal Activation during Task Switching among Cognitively Normal Elderly.Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.Is amyloid-β harmful to the brain? Insights from human imaging studies Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms.Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.Impairments of neural circuit function in Alzheimer's disease.Family history of Alzheimer's disease limits improvement in cognitive function after bariatric surgery.Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders.Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease: Methodology and Baseline Sample Characteristics.In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317.The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review.Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.

P2860

Q26772021-BB7CD9EF-01C0-4F1F-8141-7D2E2DDF6E43 Q26796235-06478820-E0CB-4BC0-8955-528D25D11758 Q26830467-78A0A0AC-3A89-43F7-9A8A-5A946711C7E3 Q33741411-AAF33DD9-AE2A-47F4-9A0A-B984AF40CA23 Q34429975-4B6F83C3-F0B3-41A4-8735-0CE4C9D5E627 Q34483878-1BC436A7-C6BC-4E11-9040-45E6194CAC67 Q34553827-1C7D445C-B10A-42B2-8BCE-2FBD6A40573A Q34555928-545EFB86-6FFE-4CDC-9F65-A77C895DA378 Q34674417-F59BF1D1-2CEE-4562-AF40-0462FE4ED74E Q35129501-BB6D8676-2F68-41F2-95C2-0BEB4E790BE6 Q35598271-7D96A3C9-42CD-4419-A761-C0631B9AED34 Q35820280-B97014BA-DC12-4698-9445-185D7FD45A61 Q35912107-9E1791E2-3A4F-4AB6-A6D8-F3FA51F44549 Q36413581-17D63BD6-708A-4AF3-9B12-C3E6A94DC813 Q36473298-4FD3A487-6E12-41D3-8290-180FD15C3C1B Q36564568-1CAEA837-EF1E-40B7-AE1F-DED83AAEE2C0 Q36651546-B8DE8817-1856-45B4-82F9-101EAF2E3D9B Q36850584-1E902197-A34B-4A14-A59C-D1BB873CA3FE Q37100074-6E2413F5-F202-4046-B58F-C4484F6E1BAD Q37188315-EE629D6E-CAB2-4254-9C59-A2F8445BFB7B Q37343162-7A52770E-900B-4244-B65C-0DB022354C17 Q37358410-F1E474D7-C8A4-4F33-A475-67112FE30CB9 Q37442011-B8104460-0D66-4DCF-8E68-E409E7E06BD0 Q38253639-AA6DAC66-1FE8-44CD-88BC-02110863D855 Q38259091-EABC549B-38EE-4BB7-9A90-40AF1FFDCF45 Q38391075-EA64F95B-DA54-49E3-88DB-DA73F2BA4B8F Q38413816-1701996C-8E9B-4B4B-AE41-9688D4C2AF4C Q38668225-90155C5E-8103-4773-AE04-59C588D720A7 Q38773531-220A9274-B6FA-45AB-AB7D-241AF162B4F5 Q38885836-70ACF602-0F2D-4D72-A16B-ABBEB1117383 Q39285235-8FE80C90-530D-472E-A093-1BE5F2AF3FB8 Q41880776-DB66698D-0278-4A6A-879D-12973984CEE6 Q43593305-B9536BA6-AA89-4CE5-9E0A-27E82FEA65E7 Q46404738-E45DC079-8191-4068-A407-EA14CAA688F1 Q47141112-2D48B767-D06F-49D7-933B-D638D2FB9819 Q47199611-00B32597-7655-419B-A157-902C2921016D Q47646484-80BE73AA-0078-417D-B0BA-FB57DD718CC6 Q47716549-B99A92D1-8488-407D-9C7F-7F4DBD6EF73A Q53685113-372312E0-AB4B-4E51-93FA-CE25D499EF48 Q55439517-36CD2F85-D0E7-49F0-85EB-AF0CE460217D

P2860

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

http://www.wikidata.org/entity/Q33599047

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

@ast

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

@en

type

label

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

@ast

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

@en

prefLabel

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

@ast

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

@en

P1433

Q33599047-2C8BB6FE-AF7C-417B-8FE3-3F0157902434

P1476

Q33599047-81ECB249-1437-48F6-9032-F439DE46E3DA

P2093

Q33599047-1CC8BD6A-5DDB-4CFF-BEA1-48263D40F338

Q33599047-20D09B7F-60B4-4C96-8319-5A00084CB2B9

Q33599047-34E02B8B-6460-426F-B295-7B316F2EC494

Q33599047-44D074CB-5F12-4865-8839-D1277C4E76A0

Q33599047-464A1A43-0A24-4F0B-A3EF-55233979A14A

Q33599047-48015429-B169-407A-8C60-E54A33A718DA

Q33599047-51F604E8-7828-4524-97C8-78443B11B069

Q33599047-6076D774-5241-4638-AF1A-82435A3D79D3

Q33599047-AD9B621F-C57E-4334-86E8-0DAEFA58F1C6

Q33599047-B2CDD1FF-FF8F-411C-837B-CCC225B75983

P2860

Q33599047-00C92B94-928E-4A0C-96DA-6BC6EF99E733

Q33599047-108A0F22-862D-4B13-8D16-D6F6182D5C09

Q33599047-126373BF-5DFF-4CBB-BFF2-C43BF9D698AE

Q33599047-14E14F80-EABC-4C44-8196-73D78FC9CAE5

Q33599047-168A073B-48E6-46F3-BF82-C77A439FF800

Q33599047-1A8645AC-DF1F-48DD-A253-6CA18C3A439B

Q33599047-1BE5A51C-6E5D-47B9-AB0D-F25DDC681262

Q33599047-1DA0E686-19BA-4122-BD39-D6A4EAADFCC3

Q33599047-209FF876-F5E7-45AB-A045-5AA7C6E2CA4C

Q33599047-26ED01C5-E0C8-4AD4-BA74-D7FA7133872C

P304

Q33599047-B39C9A1E-E46A-4CDD-8AD8-7F431D5FA480

P31

Q33599047-0EB8EA25-4DEB-4ED8-B356-818D5EF0CE1D

P356

Q33599047-3077C712-3E07-4E94-9671-9396189602BF

P433

Q33599047-DE7516F6-9EB3-4C51-9FC8-0BA830772CA6

P478

Q33599047-B958BDD2-01B4-4F3E-B46A-2819231D5469

P50

Q33599047-32A29059-3824-410E-B52A-DB5384325616

Q33599047-5A704BD1-B132-49CF-ABA2-48444A1FD9A4

Q33599047-942C0D32-2911-4BAE-A26B-95F372D99650

Q33599047-B1DA9D1C-345E-40F3-837B-153D7AEDEF89

P577

Q33599047-E4F41B93-9670-43D9-B60A-D1AAC928EEC5

P5875

Q33599047-85AB39BC-AC9D-4596-940B-0BA1346C8600

P698

Q33599047-14449D29-65F5-407E-B05A-1112BA977094

P921

Q33599047-3A2DE961-9F2E-413F-B00E-FEB20BC934B0

P932

Q33599047-585F8F35-37A3-4720-9EF7-40396925E93E

P356

J.NEUROBIOLAGING.2013.09.028

P1433

Neurobiology of Aging

P1476

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

@en

P2093

Ansel T Hillmer

http://www.w3.org/2001/XMLSchema#string

Bradley T Christian

http://www.w3.org/2001/XMLSchema#string

Bruce P Hermann

http://www.w3.org/2001/XMLSchema#string

Catherine L Gallagher

http://www.w3.org/2001/XMLSchema#string

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Cynthia M Carlsson

http://www.w3.org/2001/XMLSchema#string

Dhanabalan Murali

http://www.w3.org/2001/XMLSchema#string

Dustin W Wooten

http://www.w3.org/2001/XMLSchema#string

Guofan Xu

http://www.w3.org/2001/XMLSchema#string

Howard A Rowley

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

Voxel-based morphometry--the methods

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

Role of family history for Alzheimer biomarker abnormalities in the adult children study

Alzheimer's disease: the amyloid cascade hypothesis

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

In vivo assessment of amyloid-β deposition in nondemented very elderly subjects

P304

576-584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2013.09.028

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

William E. Klunk

Todd E. Barnhart

Barbara B Bendlin

P577

2013-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258852734

http://www.w3.org/2001/XMLSchema#string

P698

24269021

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4018215

http://www.w3.org/2001/XMLSchema#string